Fundz

Butterfly Medical raised $21 million in Series C funding to advance its non-surgical BPH treatment with lead investors including the European Innovation Council and Junson Capital.

PRIVATEMay 14, 2026

Amount Raised

$21 Million

Round Type

Series C

YokneamBiotechnologyHealth CareMedicalMedical Device

Investors

MedVentureNew Rhein Healthcare InvestorsEuropean Innovation CouncilJunson Capital

Description

Butterfly Medical has successfully completed its Series C funding round, raising $21 million to support its FDA regulatory path and global commercialization efforts. The financing round saw strong institutional demand and included participation from various investors. CEO Patrick MacCarthy emphasized the clinical potential and market opportunity for their prostatic retraction device. The company will showcase its technology at the AUA 2026 Annual Meeting in Washington, D.C.

Quick answer

Butterfly Medical Ltd raised $21 Million in a Series C round, dated May 14, 2026. Investors: MedVenture, New Rhein Healthcare Investors, European Innovation Council and Junson Capital. Butterfly Medical Ltd is based in Yokneam, Northern District, Israel.

How much did Butterfly Medical Ltd raise?
Butterfly Medical Ltd raised $21 Million in a Series C round on May 14, 2026.
Who invested in Butterfly Medical Ltd?
MedVenture, New Rhein Healthcare Investors, European Innovation Council and Junson Capital are named as investors in this round.
What does Butterfly Medical Ltd do?
Butterfly Medical's purpose is to improve the quality of life for patients suffering from Benign Prostatic Hyperplasia (BPH).
Where is Butterfly Medical Ltd based and how big is it?
Butterfly Medical Ltd is based in Yokneam, Northern District, Israel.
Who are the decision-makers at Butterfly Medical Ltd?
Fundz holds 1 contact at Butterfly Medical Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Butterfly Medical Ltd that raised within 45 days of this round, from Fundz verified event records.

  • PreTel raised $50K (Seed) on June 28, 2026.
  • Magdent raised $150K (Pre-Seed) on June 26, 2026.
  • Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
  • Grail raised $110M (Post-IPO Equity) on June 25, 2026.
  • Kinomatic raised $4M (Seed) on June 18, 2026.
  • Icarus Medical raised $7.2M (Series A) on June 17, 2026.

Who to call at Butterfly Medical Ltd, and when

A new round usually means Butterfly Medical Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Butterfly Medical Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Butterfly Medical Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Butterfly Medical Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Butterfly Medical Ltd

Location

Yokneam, Northern District, Israel

About

Butterfly Medical's purpose is to improve the quality of life for patients suffering from Benign Prostatic Hyperplasia (BPH). With a team of seasoned medical, technical, clinical and commercial experts, we have created a novel device and ground-breaking procedure to mechanically and minimally invasively open the prostatic urethra in men with BPH.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Butterfly Medical Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Butterfly Medical Ltd's next move

See what Strategic adds

Butterfly Medical Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.